Sun, 08 Nov 2026  |  02:53:09 AM
SENSEX81,028.02
▲ 1,718.01
NIFTY 5025,030.35
▲ 493.75
BANK NIFTY59,086.00
▲ 1,312.35
INDIA VIX17.47
▲ 1.89
Home› News› SoftBank Sells Lenskart Shares Worth Rs 1,896 Crore in Block Deal
Business News

SoftBank Sells Lenskart Shares Worth Rs 1,896 Crore in Block Deal

07 November 2026, 6:32 AM Nikhil Bhatt 19 views
SoftBank Sells Lenskart Shares Worth Rs 1,896 Crore in Block Deal

SoftBank has offloaded Lenskart shares valued at Rs 1,896 crore through a block deal, while the promoter of Alivus Life Sciences has sold a 2.3% stake in the company. A block deal refers to a single transaction involving a large number of securities that is executed outside the open market to avoid price volatility. These transactions represent significant shifts in shareholding patterns for the involved entities as large investors adjust their current portfolios.

The sale of shares by SoftBank marks a notable movement of capital involving the eyewear firm. Simultaneously, the reduction of the stake held by the Alivus Life Sciences promoter indicates a change in the ownership structure of that business. Market participants often monitor these large-volume trades to understand how major stakeholders are rebalancing their positions within their respective investment portfolios.

These movements took place through standard market mechanisms designed to facilitate the transfer of large equity blocks between institutional and private entities. Such activities are common in the financial markets and provide liquidity for exiting investors while allowing new participants to acquire stakes. The details of these specific transactions reflect the current activity level among major shareholders and promoters in the Indian corporate landscape today.

What it means for investors: These block deals highlight significant equity transfers that can influence market sentiment regarding the specific companies involved. Investors typically observe these large transactions to track the movements of major institutional players and promoters who hold substantial portions of company equity.

LenskartSoftBankAlivus Life Sciencesblock dealIndian stock marketinvestment newsshare sale

Disclaimer :

Investments in the securities market are subject to market risks. All content and Index / securities mentioned are strictly for educational and journalistic purposes and do not constitute personalized buy, sell, or hold investment recommendations, Please read all related documents and full disclosures at nikhilbhatt.in before investing.

Facebook Instagram LinkedIn Mail Telegram YouTube WhatsApp